Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rate (“ETR”) was 99.4% for the three months ended September 30, 2020 and 123.9% for the three months ended September 30, 2019. The Company’s ETR was 20.8% for the nine months ended September 30, 2020 and 33.4% for the nine months ended September 30, 2019. The ETR differs from the 21.0% U.S. Federal statutory rate primarily due to the change in valuation allowance, tax permanent differences, and discrete items recorded in each of the respective periods. The discrete items for the nine months ended September 30, 2020 are primarily attributable to a partial release of uncertain tax positions due to favorable developments with ongoing U.S. federal tax examinations. As of September 30, 2020 and December 31, 2019, the amount of unrecognized tax benefits was $28.2 million and $48.3 million excluding interest and penalties, respectively, of which up to $28.2 million and $48.3 million, respectively, would affect the Company's effective tax rate if realized as of their respective periods. As of September 30, 2020 and December 31, 2019, the Company had $8.5 million and $10.7 million, respectively, recorded for interest in the condensed consolidated balance sheets. The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. The Company expects to complete resolution of certain tax years with various tax authorities within the next 12 months. The Company believes it is reasonably possible that its existing gross unrecognized tax benefits may be reduced by up to $26.6 million within the next 12 months, affecting the Company’s effective tax rate if realized. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted and signed into law. The CARES Act includes several provisions for corporations including increasing the amount of deductible interest, allowing companies to carryback certain Net Operating Losses (“NOLs”) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not materially affect the Company's year-to-date income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's condensed consolidated financial statements, but do not expect the impact to be material.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.